Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuyi Liu

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|September 2, 2022
Discovery of Novel Imidazo[4,5-<i>c</i>]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal HomeostasisXuewu Liang, Yongle Xie, Xuyi Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2009
EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancerMeina Wu, Jun Zhao, Sonya Wei Song, et al.
Mbio|February 20, 2024
DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1Ying Miao, Tingting Zhang, Mingcheng Guan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 12, 2012
[A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China]Longyun Li, Wei Zhong, Meilin Liao, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|September 2, 2022
Discovery of Novel Imidazo[4,5-<i>c</i>]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal HomeostasisXuewu Liang, Yongle Xie, Xuyi Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2009
EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancerMeina Wu, Jun Zhao, Sonya Wei Song, et al.
Mbio|February 20, 2024
DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1Ying Miao, Tingting Zhang, Mingcheng Guan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 12, 2012
[A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China]Longyun Li, Wei Zhong, Meilin Liao, et al.
Pageof 5